106. The representative of China recalled that the adoption of the 2003 Decision by the General Council had been a historical moment. The 2003 Decision was the first result that had been achieved by WTO Members through consensus under the Doha mandate. Her delegation continued to feel very encouraged by this achievement in the field of public health, especially considering the fact that the Doha Round negotiations on other topics were currently stalled. By waiving Members' obligations under Article 31(f) of the TRIPS Agreement, the System allowed poorer countries to make full use of TRIPS flexibilities in order to deal with diseases that ravaged their people. Whether it had completely achieved its objectives was not easy to assess. Many Members were facing public health challenges from time to time, but the System had been used only once so far. Its review was therefore necessary in order to improve it. During the past annual reviews, Members had also discussed the broader issues related to innovation of and access to medicines, including those on the list of topics and issues that had been circulated by the Chair in 2011. However, the difficulties in using the System and possible improvements had not been clearly identified. Her delegation therefore agreed with the approach suggested by the Chair, of encouraging Members to pose more questions for the purposes of conducting future annual reviews. She reiterated her delegation's support for the organization of a dedicated workshop that would allow to gather information from all relevant stakeholders so that answers could be found to some of the open issues
